课题基金 / 基金详情

PARACEST Agents: Optimization for Human MR Imaging

PARACEST Agents: Optimization for Human MR Imaging
PARACEST 代理:优化人体 MR 成像
批准号:
7125381
负责人:
ROBERT E LENKINSKI
金额:
$102.8万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2009-08-31
关键词:

项目摘要

项目成果

ROBERT E LENKINSKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Paramagnetic chemical exchange saturation transfer (PARACEST) agents offer a potential new paradigm in MR imaging. An advantage to this class of agents is the ability to switch each agent on or off through selective RF irradiation applied at the frequency of either its bound water resonance or an exchanging NH group. This feature means that multiple, targeted PARACEST agents can be injected together and their effects imaged either sequentially or simultaneously. In their "off" state, i.e. when not specifically irradiated, PARACEST agents will not interfere with conventional MR imaging sequences, with or without gadolinium. In principle, PARACEST agents can be tailored to each application because their effects depend on their water exchange rates, and these rates can be modified using rational chemical principles. This feature also makes them an attractive platform for the development of responsive agents and bifunctional agents. The goal of this BRP is to realize the full potential of these compounds as contrast agents in vivo, by systematically addressing a number of basic, theoretical and practical questions. These include establishing the relationships among the magnitude of the effect measured in an imaging experiment and the water exchange lifetime, the magnitude of the chemical shift difference between the bound and bulk water, the strength of the saturating RF field, SAR, concentration, and local environment in vivo. This partnership is made up of two academic institutions and an industrial collaborator. The three main overlapping and interactive areas of focus are: lanthanide chemistry, which will be carried out at UT Dallas (UTD); Pulse sequence implementation, theory, simulations and in vitro validation which will be carried out primarily at the General Electric Global Research Center (GEGRC) and in vivo validation carried out primarily at the BIDMC. Dean Sherry (Project Leader, UTD) is an internationally recognized expert in the synthesis and characterization of lanthanide chelates. Donald Woessner (Lead Investigator, UTD), an internationally recognized expert in basic NMR exchange theory.Thomas Dixon and lleana Hancu (Project Leaders, GEGRC) are both experts in NMR and MR imaging. Robert Lenkinski (PI, BIDMC) is an NMR spectroscopist with expertise both in lanthanide agents and MR imaging. David Alsop (Lead Investigator, BIDMC) has a long track record in optimizing Arterial Spin Labeling perfusion studies, where the detection of small signal intensity changes in the presence of RF irradiation is necessary. Over the past several years, this team has been collaborating on the theoretical and practical aspects of the PARACEST effect. The successful completion of this project will result in a set of agents and MR acquisition strategies for use in human studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OPTIMIZING PARACEST AGENTS FOR HUMAN MR IMAGING
  • 批准号:
    8363909
  • 项目类别:
  • 资助金额:
    $1.61万
  • 财政年份:
    2011
  • 负责人:
    ROBERT E LENKINSKI
  • 依托单位:
EXTERNAL ADVISORY COMMITTEE
  • 批准号:
    8363922
  • 项目类别:
  • 资助金额:
    $0.8万
  • 财政年份:
    2011
  • 负责人:
    ROBERT E LENKINSKI
  • 依托单位:
OPTIMIZING PARACEST AGENTS FOR HUMAN MR IMAGING
  • 批准号:
    8171660
  • 项目类别:
  • 资助金额:
    $1.05万
  • 财政年份:
    2010
  • 负责人:
    ROBERT E LENKINSKI
  • 依托单位:
EXTERNAL ADVISORY COMMITTEE
  • 批准号:
    8171673
  • 项目类别:
  • 资助金额:
    $0.52万
  • 财政年份:
    2010
  • 负责人:
    ROBERT E LENKINSKI
  • 依托单位:
国内基金
海外基金
基于术中实时影像的SAM(Segment anything model)开发AI指导房间隔穿刺位置决策的增强现实模型
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    居维竹
  • 依托单位:
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
  • 批准号:
    82370684
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    傅强
  • 依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
  • 批准号:
    82371912
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    吴广宇
  • 依托单位:
高维隐含因子与定价误差的协同估计
  • 批准号:
    72101226
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    丁一
  • 依托单位: